PRF1 and diabetes mellitus: This may offer anti-Fas antibody therapy against β-cell destruction in patients with poor blood glucose control, however, studies on the role of Fas in DM reported so far were limited to a T-cell-mediated autoimmune model, in which perforin rather than Fas plays a crucial role, and the role of Fas remains controversial [26,27,28].